Biocom’s top priority is the safety of our members and the well-being of our employees. After careful consideration, Biocom has decided to transform our 2021 Global Life Science Partnering Conference to a fully virtual event. We know that many lives are being impacted and disrupted by COVID-19 and we are grateful to be able to continue offering our members valuable content in a safe manner.
Senior Vice President, Search and Evaluation & Alliance Management, Global Business Development, Daiichi Sankyo
Dr. Warmke is currently Senior Vice President of Global Business Development, Daiichi Sankyo Group, and leads the Search and Evaluation group responsible for identification and evaluation of product licensing and R&D collaboration opportunities. He also heads the co-development partner Alliance Management function.With the formation of Daiichi Sankyo Pharma Development in 2006, Dr. Warmke was appointed co-leader of the Global Project Management function and served as a member of Daiichi Sankyo’s Global R&D Management Committee. In his current position, he is a member of the Senior Licensing Committee and works directly with global senior management on licensing and research & development collaboration projects.
Prior to Sankyo Pharma Development, Dr. Warmke was at Merck Research Laboratories where he held positions of increasing responsibility in discovery research and project planning and management.